Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PCNSL (Primary CNS Lymphoma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03188354
What this trial is testing

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinCentral Nervous System Neoplasms
Norwegian University of Science and Technology 3
Testing effectiveness (Phase 2)WithdrawnNCT00003929
What this trial is testing

Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT03703167
What this trial is testing

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00082836
What this trial is testing

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT03569995
What this trial is testing

[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma
Won Seog Kim 35
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Study completedNCT03495960
What this trial is testing

Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Who this might be right for
Primary Central Nervous System Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 72
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06901999
What this trial is testing

Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Who this might be right for
CNS Lymphoma
Ruijin Hospital 23
Testing effectiveness (Phase 2)WithdrawnNCT00712062
What this trial is testing

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
University of Florida
Testing effectiveness (Phase 2)Study completedNCT01083342
What this trial is testing

High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

Who this might be right for
CNS Lymphoma
Samsung Medical Center 36
Early research (Phase 1)UnknownNCT05135858
What this trial is testing

Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 18
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Not applicableUnknownNCT03582254
What this trial is testing

Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 62
Early research (Phase 1)Study completedNCT00416923
What this trial is testing

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03220646
What this trial is testing

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain Tumor
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT03328078
What this trial is testing

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Who this might be right for
Relapsed Hematologic MalignancyRefractory Hematologic MalignancyRelapsed Primary Central Nervous System Lymphoma+1 more
Curis, Inc. 152
Testing effectiveness (Phase 2)Study completedNCT01458730
What this trial is testing

Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Who this might be right for
Central Nervous System Lymphoma
University of Aarhus 66
Testing effectiveness (Phase 2)Ended earlyNCT00335140
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 26
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Next Page